No controlled KLOW trial has tested this schedule or established when skin changes should appear
Eli Lilly reported these results in mid-2025, and the retatrutide availability timeline now points toward potential FDA approval no earlier than 2027, as additional phase 3 trials continue
Since this article can't resolve that conflict for you, use the longer 72-hour window as your working deadline, and get written confirmation from customer service of your specific cancellation date
Whether you're recovering from an injury, managing a chronic condition, or simply want to feel your best, our team is here to guide you every step of the way
Neck: The neck area tends to respond slower than the face
Drew Timmermans: Oh, big question